Knesset enacts medical cannabis export law

Cannabis
Cannabis

The law still requires approval by the Israeli cabinet to enable exports to go ahead.

The medical cannabis export law proposed by MK Yoav Kisch (Likud) has been approved on its second and third Knesset readings. Approval was rushed through the Knesset in order to facilitate exports before the Knesset disperses. 21 MKs voted in favor of the law, with no votes cast against.

The law budgets cannabis supervision by the Ministry of Public Security. Following passage of the law, Minister of Public Security Gilad Erdan and his ministry, the only official opposition to the law, will no longer oppose it. The other ministries involved - the Ministry of Health, Ministry of Agriculture and Rural Development, Ministry of Justice, Ministry of Finance, and Ministry of Social Equality - previously expressed support for legalizing exports and supported it on previous occasions.

The issue of exports will now be referred to the cabinet. The law regulates export procedures, but does not yet constitute official approval for exports; only a positive cabinet decision will enable exports to go ahead. Sources close to the cabinet believe that the decision will pass unless vetoed by Prime Minister Benjamin Netanyahu. If the cabinet does grant approval, actual exports can begin in 6-8 months.

Adv. Hagit Weinstock of the Weinstock Zehavi & Co. law firm, who represents medical cannabis growers, entrepreneurs, and investors, said that the question of exports would be brought to the government for discussion in the coming weeks. "I welcome the passage of the amendment to the Dangerous Drugs Ordinance on its second and third readings," she said. "This now an opportunity for the Israeli government to put an end to this saga and approve cannabis exports before the elections. We must not be forced to wait another six months for it to be brought to the next government for approval."

When the question of exports was brought before the cabinet for an official government decision last April, Prime Minister Benjamin Netanyahu rejected it and sought to convene a committee to examine the matter. Cannabis industry sources alleged at the time that Netanyahu had decided against approving exports for reasons known only to him that were not related to the opposition by the Ministry of Public Security. Among other things, it was suggested that Netanyahu's attitude was influenced by US President Donald Trump's opposition, or even by the views of Sheldon Adelson, a known opponent of legalization or medicalization of cannabis.

Kisch's law stipulates that every medical cannabis license will be contingent on a license from the Ministry of Health. Regulations were established stating that Israel Police would make a recommendation for any party requesting a license to engage in medical cannabis business: a positive recommendation, a negative one, or announcement of an exemption from a recommendation. If a foreign investor is involved, the police can say that it lacks sufficient information (as it has done hitherto). The law also states that the police must issue a recommendation within four months, or within six months for a foreign investor. In the version drawn up by Netanyahu's committee, violators of the license terms are subject to a two-year prison term or a NIS 75,000 fine.

Estimations of potential revenue from Israeli cannabis exports vary greatly from NIS 250 million, according to Prof. Avi Simhon, whom Netanyahu appointed to examine the matter, to NIS 4 billion by Minister of Agriculture and Rural Development Uri Ariel a year ago. It is clear, however, that the opportunity is dwindling as time passes without exports from Israel being approved, while other countries are developing in this direction.

Eight cannabis growing companies and a number of cannabis products production, marketing, and distribution companies currently operate in Israel. Dozens of farmers with licenses in principle to grow cannabis are waiting for a decision about exports in order to go ahead with activity in the field.

Adv. Reut Alfiah, partner and head of the cannabis department at global law firm ZAG - S&W said, "Israel has an advantage in the developing and growing of medicinal cannabis. However, regulatory constraints have thus far prevented the realization of this huge potential. Meanwhile, the train has long left the station in other countries while Israel was lagging behind. The amendment of the law will finally enable unlocking the potential of this industry in Israel. Cannabis farming will flourish, R&D will grow and foreign investors who regard Israel as the category leader will be able to invest in Israeli cannabis companies. The State coffers too will see significant revenues from this industry."

Published by Globes, Israel business news - en.globes.co.il - on December 25, 2018

© Copyright of Globes Publisher Itonut (1983) Ltd. 2018

groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment on TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Tomer Weingarten Photo: PR Trump targets SentinelOne exec in act of revenge

The US administration has suspended the security clearance of the company's chef intelligence and public policy officer Chris Krebs and everyone associated with him.

Tel Aviv Stock Exchange share prices rising credit: Tali Bogdanovsky TASE opens sharply higher after Trump U-turn on tariffs

The pause is being interpreted as a climb down after US President Donald Trump admitted he had made the move to calm the markets.

Ashot Ashkelon credit: Ministry of Defense Up 250%, Ashot Ashkelon wins another Defense Ministry order

The Israeli defense company's share price has risen 250% in the past three years since FIMI Opportunity Funds acquired control.

Liad Agmon credit: Eyal Izhar Insight Partners Liad Agmon steps down as managing partner

Serial entrepreneur Agmon has served as a partner at Insight Partners Israel alongside Daniel Aronovitz who set up the Israel office.

Shekels credit: Shutterstock Vladerina32 Shekel slide resumes amid escalating tariff war

The Bank of Israel is not expected to intervene in the forex market despite the sharp depreciation of the shekel.

Nir Zuk credit: Inbal Marmari Palo Alto Networks mulls buying AI security co for $700m

Sources inform "Globes" that on Palo Alto's radar is Protect AI.

President Donald Trump hosts Prime Minister Benjamin Netanyahu credit: Reuters Kevin Mohatt Israeli officials confident on US tariff concessions

Senior Israeli figures believe that concessions could be tied to progress on strategic regional political issues that are important to President Trump.

Phoenix Investment House CEO Avner Hadad  credit: Tommy Harpaz "The market has priced in all the bad things"

Phoenix Investment House CEO Avner Hadad says US markets could continue to fall, but that we are close to interesting territory for patient investors.

Tel Aviv credit: Shutterstock Tel Aviv slips in World's Wealthiest Cities ranking

Tel Aviv's position as one of the world's wealthiest cities took a big knock over the past year as it slipped from 42nd to 48th in investment advisors Henley & Co.'s "World's Wealthiest Cities" Top 50 ranking.

Leviathan platform  credit: Albatross C'ttee seen recommending no cut in gas exports

The Dayan committee on the future of the gas sector estimates that Israel's natural gas reserves will run out in 2045.

Accountant General Yali Rothenberg credit: Rafi Kutz Israel's fiscal deficit continues to narrow

The deficit narrowed in the twelve months to the end of March 2025, for the sixth consecutive month, Ministry of Finance accountant general Yali Rothenberg reported today.

Arkia credit: Arkia Arkia cuts Tel Aviv - New York April fares

Arkia has cut fares at the last minute, a time when prices usually soar even higher, according to the pricing method used in the industry.

Bank of Israel Governor Prof. Amir Yaron credit: Dani Shem Tov Knesset Spokesperson BoI Governor: US tariffs could push up inflation in Israel

Prof. Amir Yaron tells "Globes" that there is a risk that the new tariffs will cause inflation to rise in the US, with a knock-on effect for Israel.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018